Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-13 11:20 AM View:  | Sj Strategic Investments LLC 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 04-Mar-13 | Purchase | 1,250,000 | -- | -- | 22% 5.59M to 6.84M | |
| 06-Mar-13 11:18 AM View: | Gregory John M Director 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 04-Mar-13 | Purchase | 625,000 | -- | -- | 11% 5.59M to 6.21M | |
| 06-Mar-13 11:20 AM View: | Sj Strategic Investments LLC 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 04-Mar-13 | Purchase | 1,250,000 | -- | -- | 18% 6.84M to 8.09M | |
| 06-Mar-13 11:18 AM View: | Gregory John M Director 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 04-Mar-13 | Purchase | 1,875,000 | -- | -- | 30% 6.21M to 8.09M | |
| 04-Mar-13 6:56 PM View: | Thrasher Francis Martin Director | Tribute Pharmaceuticals Can... (NONE) | 27-Feb-13 | Market Purchase | 1,250,000 | $0.40 | $500,000.00 | 100% 0 to 1.25M | (8%) |
| 04-Mar-13 6:44 PM View: | Tenney Arnold Chairman Director | Tribute Pharmaceuticals Can... (NONE) | 27-Feb-13 | Market Purchase | 250,000 | $0.40 | $100,000.00 | 36% 692.7K to 942.7K | (8%) |
| 04-Mar-13 7:19 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 27-Feb-13 | Market Purchase Duplicate | 1,250,000 | $0.40 | $500,000.00 | 42% 3.01M to 4.26M | (8%) |
| 04-Mar-13 5:58 PM View: | Elora Financial Management ... CFO Director 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 27-Feb-13 | Market Purchase | 62,500 | $0.40 | $25,000.00 | < 1% 6.75M to 6.81M | (8%) |
| 20-Mar-13 7:42 PM View: | Harris Robert Paul Chief Executive Officer Director | Tribute Pharmaceuticals Can... (NONE) | 27-Feb-13 | Market Purchase | 625,000 | $0.40 | $250,000.00 | 4% 16.5M to 17.13M | (8%) |
| 21-Nov-12 1:34 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 19-Nov-12 | Market Purchase | 100,000 | $0.35 | $35,000.00 | 9% 1.13M to 1.23M | 6% |
| 12-Sep-12 8:53 AM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 07-Sep-12 | Purchase | 25,000 | $0.50 | $12,500.00 | 2% 1.0M to 1.03M | |
| 06-Sep-12 9:36 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 05-Sep-12 | Purchase | 84,500 | $0.50 | $42,000.00 | 4% 2.04M to 2.13M | |
| 06-Sep-12 9:36 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 04-Sep-12 | Purchase | 20,500 | $0.50 | $10,250.00 | 1% 2.02M to 2.04M | |
| 31-Aug-12 6:26 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 31-Aug-12 | Purchase | 35,000 | $0.48 | $16,695.00 | 4% 965.15K to 1.0M | |
| 29-Aug-12 5:09 PM View: | Gregory John M Director 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 27-Aug-12 | Purchase | 400,000 | $0.49 | $197,392.00 | 8% 5.19M to 5.59M | |
| 29-Aug-12 8:49 AM View: | Tenney Arnold Chairman Director | Tribute Pharmaceuticals Can... (NONE) | 27-Aug-12 | Market Purchase | 20,000 | $0.38 | $7,600.00 | 2% 884.2K to 904.2K | (3%) |
| 29-Aug-12 9:01 AM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 27-Aug-12 | Market Purchase | 40,000 | $0.38 | $15,200.00 | 4% 925.15K to 965.15K | (3%) |
| 29-Aug-12 5:14 PM View: | Sj Strategic Investments LLC 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 27-Aug-12 | Purchase Duplicate | 400,000 | $0.49 | $197,392.00 | 8% 5.19M to 5.59M | |
| 20-Mar-13 7:42 PM View: | Harris Robert Paul Chief Executive Officer Director | Tribute Pharmaceuticals Can... (NONE) | 22-Mar-12 | Purchase | 550,000 | $0.56 | $308,000.00 | 4% 14.85M to 15.4M | |
| 28-Feb-13 10:53 AM View: | Elora Financial Management ... CFO Director 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 22-Mar-12 | Purchase | 900,000 | $0.56 | $504,000.00 | 15% 5.85M to 6.75M | |
| 20-Mar-13 7:42 PM View: | Harris Robert Paul Chief Executive Officer Director | Tribute Pharmaceuticals Can... (NONE) | 22-Mar-12 | Purchase | 550,000 | $0.56 | $308,000.00 | 4% 15.4M to 15.95M | |
| 28-Dec-11 7:21 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 28-Dec-11 | Grant | 8,700 | $0.64 | $5,568.00 | < 1% 1.79M to 1.79M | |
| 06-Jan-12 6:42 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 27-Dec-11 | Grant | 5,300 | $0.62 | $3,286.00 | < 1% 919.85K to 925.15K | |
| 06-Jan-12 6:42 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 23-Dec-11 | Grant | 18,500 | $0.65 | $12,110.00 | 2% 901.35K to 919.85K | |
| 28-Dec-11 7:21 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 22-Dec-11 | Grant | 15,000 | $0.62 | $9,300.00 | < 1% 1.77M to 1.79M | |
| 21-Dec-11 5:55 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 20-Dec-11 | Grant | 39,000 | $0.67 | $26,007.00 | 5% 838.65K to 877.65K | |
| 20-Dec-11 3:44 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 19-Dec-11 | Grant | 10,000 | $0.64 | $6,375.00 | < 1% 1.66M to 1.67M | |
| 20-Dec-11 3:44 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 15-Dec-11 | Grant | 50,000 | $0.66 | $33,000.00 | 3% 1.61M to 1.66M | |
| 14-Dec-11 6:33 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 14-Dec-11 | Grant | 67,200 | $0.66 | $44,360.00 | 5% 1.46M to 1.53M | |
| 13-Dec-11 5:48 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 09-Dec-11 | Grant | 62,400 | $0.64 | $39,897.50 | 5% 1.33M to 1.39M | |
| 09-Dec-11 8:48 AM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 05-Dec-11 | Grant | 119,692 | $0.59 | $70,811.90 | 23% 529.35K to 649.05K | |
| 06-Dec-11 10:44 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 29-Nov-11 | Private Sale | 25,000 | $0.55 | $13,750.00 | (< 1%) 6.52M to 6.5M | |
| 06-Dec-11 10:44 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 28-Nov-11 | Private Sale | 25,000 | $0.53 | $13,250.00 | (< 1%) 6.55M to 6.52M | |
| 01-Dec-11 10:44 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 15-Nov-11 | Private Sale | 14,275 | $0.50 | $7,137.50 | (< 1%) 3.3M to 3.29M | |
| 01-Dec-11 10:44 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 09-Nov-11 | Private Sale | 7,300 | $0.50 | $3,650.00 | (< 1%) 3.31M to 3.3M | |
| 26-Oct-11 2:49 PM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 20-Oct-11 | Private Sale | 9,590 | $0.51 | $4,890.90 | (< 1%) 3.32M to 3.31M | |
| 26-Oct-11 2:49 PM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 18-Oct-11 | Private Sale | 20,000 | $0.44 | $8,800.00 | (< 1%) 3.34M to 3.32M | |
| 03-Aug-11 11:52 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 26-Jul-11 | Private Purchase | 3,000 | $0.62 | $1,860.00 | (< 1%) 3.34M to 3.34M | |
| 03-Aug-11 11:52 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 25-Jul-11 | Private Purchase | 17,380 | $0.62 | $10,775.60 | (< 1%) 3.36M to 3.34M | |
| 28-Jul-11 9:19 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 20-Jul-11 | Purchase | 12,620 | $0.62 | $7,824.40 | < 1% 3.35M to 3.36M | |
| 06-May-11 9:53 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 21-Apr-11 | Private Purchase | 13,735 | $0.72 | $9,889.20 | (< 1%) 3.38M to 3.37M | |
| 19-Apr-11 2:35 PM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 12-Apr-11 | Private Purchase | 50,000 | $0.68 | $34,025.00 | (1%) 3.43M to 3.38M | |
| 13-Apr-11 9:50 AM View: | Riehl Peter Roy 10% Owner | Tribute Pharmaceuticals Can... (NONE) | 05-Apr-11 | Private Purchase | 40,000 | $0.50 | $20,200.00 | (< 1%) 6.93M to 6.89M | |
| 13-Dec-10 9:24 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 10-Dec-10 | Disposition (other) | 463,814 | $0.36 | $166,973.00 | (50%) 927.63K to 463.81K | (3%) |
| 13-Dec-10 9:24 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 10-Dec-10 | Acquisition (other) | 463,814 | $0.36 | $166,973.00 | 100% 463.81K to 927.63K | 3% |
| 31-Aug-10 4:17 PM View: | Goldman Steven Harold Director | Tribute Pharmaceuticals Can... (NONE) | 26-Aug-10 | Private Sale | 265 | $0.86 | $227.90 | (< 1%) 464.08K to 463.81K | |
| 02-Jul-10 11:34 AM View: | Clarke Janice Marie Chief Financial Officer | Tribute Pharmaceuticals Can... (NONE) | 30-Jun-10 | Expiration | 30,000 | $0.65 | $19,500.00 | 36% 82.22K to 112.22K | |
| 02-Jul-10 11:34 AM View: | Clarke Janice Marie Chief Financial Officer | Tribute Pharmaceuticals Can... (NONE) | 30-Jun-10 | Purchase | -- | -- | -- | 0% 112.22K | |
| 02-Jul-10 11:34 AM View: | Clarke Janice Marie Chief Financial Officer | Tribute Pharmaceuticals Can... (NONE) | 30-Jun-10 | Private Sale | 21,800 | $0.90 | $19,620.00 | (19%) 112.22K to 90.42K | |
| 24-Sep-07 5:13 PM View: | Clarke Janice Marie Chief Financial Officer | Tribute Pharmaceuticals Can... (NONE) | 24-Sep-07 | Market Purchase | 5,500 | $0.52 | $2,860.00 | 7% 76.72K to 82.22K | (41%) |
